Ischemia modified albumin (IMA), as measured using the albumin cobalt binding test, is currently the most promising biomarker for early detection of ischemia before the onset of irreversible cardiac injury. The aim of the study was to evaluate a possible association between IMA values and gynecologic malignancy.

Ischemia modified albumin in gynecologic malignancies

LIPPI, Giuseppe;SALVAGNO, GIAN LUCA;GIUDICI, Silvia;FRANCHI, Massimo Piergiuseppe;
2006

Abstract

Ischemia modified albumin (IMA), as measured using the albumin cobalt binding test, is currently the most promising biomarker for early detection of ischemia before the onset of irreversible cardiac injury. The aim of the study was to evaluate a possible association between IMA values and gynecologic malignancy.
IMS; ischemia; gynecologic malignancy
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/11562/430374
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact